EUTM file information

018565377

Translate Bio


September 23, 2021

Trademark Summary

The trademark application Translate Bio was filed by Translate Bio, Inc. A Delaware Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on October 18, 2021, and it was registered by office on January 25, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders
    2. Medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders
    3. Biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders
    4. Biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders
    5. Biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders
    6. Therapeutic and prophylactic vaccines.
  • The mark was filed in class 42 with Medical and scientific research.
Trademarkers